PCVX - Company ID 0001649094
As of 2026-11-06, Vaxcyte, Inc. (PCVX) has a market capitalization of $9.33 B, making it the #962 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $9.33 B |
| 2026-11-05 | $9.48 B |
| 2026-11-04 | $9.48 B |
| 2026-11-03 | $8.78 B |
| 2026-11-02 | $8.76 B |
| 2026-11-01 | $8.96 B |
| 2026-10-31 | $8.96 B |
| 2026-10-30 | $8.94 B |
| 2026-10-29 | $9.10 B |
| 2026-10-28 | $8.87 B |
| 2026-10-27 | $8.76 B |
| 2026-10-26 | $8.66 B |
As of 2026-11-06, Vaxcyte, Inc. (PCVX) has a market capitalization of $9.33 B, making it the #962 most valuable US-listed company.
Vaxcyte, Inc. is the #962 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $8.73 B |
| 2026-10-24 | $8.73 B |
| 2026-10-23 | $8.80 B |
| 2026-10-22 | $9.08 B |
| 2026-10-21 | $9.25 B |
| 2026-10-20 | $9.63 B |
| 2026-10-19 | $9.20 B |
| 2026-10-18 | $9.19 B |
| 2026-10-17 | $9.19 B |
| 2026-10-16 | $9.14 B |
| 2026-10-15 | $9.42 B |
| 2026-10-14 | $9.75 B |
| 2026-10-13 | $9.80 B |
| 2026-10-12 | $10.04 B |
| 2026-10-11 | $10.31 B |
| 2026-10-10 | $10.31 B |
| 2026-10-09 | $10.31 B |
| 2026-10-08 | $9.50 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.